Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients

Background: Widespread neural and microvascular injuries are common in chronic kidney disease (CKD), increasing risks of neurovascular complications and mortality. Early detection of such changes helps assess the risks of neurovascular complications for CKD patients. As an extension of central nervo...

Full description

Bibliographic Details
Main Authors: Xiaomin Zeng, Yijun Hu, Yuanhan Chen, Zhanjie Lin, Yingying Liang, Baoyi Liu, Pingting Zhong, Yu Xiao, Cong Li, Guanrong Wu, Huiqian Kong, Zijing Du, Yun Ren, Ying Fang, Zhiming Ye, Xiaohong Yang, Honghua Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2021.703898/full
_version_ 1818402057383575552
author Xiaomin Zeng
Xiaomin Zeng
Yijun Hu
Yijun Hu
Yuanhan Chen
Zhanjie Lin
Zhanjie Lin
Yingying Liang
Yingying Liang
Baoyi Liu
Baoyi Liu
Pingting Zhong
Pingting Zhong
Yu Xiao
Yu Xiao
Cong Li
Cong Li
Guanrong Wu
Guanrong Wu
Huiqian Kong
Huiqian Kong
Zijing Du
Zijing Du
Yun Ren
Yun Ren
Ying Fang
Zhiming Ye
Xiaohong Yang
Xiaohong Yang
Honghua Yu
Honghua Yu
author_facet Xiaomin Zeng
Xiaomin Zeng
Yijun Hu
Yijun Hu
Yuanhan Chen
Zhanjie Lin
Zhanjie Lin
Yingying Liang
Yingying Liang
Baoyi Liu
Baoyi Liu
Pingting Zhong
Pingting Zhong
Yu Xiao
Yu Xiao
Cong Li
Cong Li
Guanrong Wu
Guanrong Wu
Huiqian Kong
Huiqian Kong
Zijing Du
Zijing Du
Yun Ren
Yun Ren
Ying Fang
Zhiming Ye
Xiaohong Yang
Xiaohong Yang
Honghua Yu
Honghua Yu
author_sort Xiaomin Zeng
collection DOAJ
description Background: Widespread neural and microvascular injuries are common in chronic kidney disease (CKD), increasing risks of neurovascular complications and mortality. Early detection of such changes helps assess the risks of neurovascular complications for CKD patients. As an extension of central nervous system, the retina provides a characteristic window to observe neurovascular alterations in CKD. This study aimed to determine the presence of retinal neurovascular impairment in different stages of CKD.Methods: One hundred fifteen non-diabetic and non-dialytic CKD patients of all stages and a control group of 35 healthy subjects were included. Retinal neural and microvascular parameters were obtained by optical coherence tomography angiography (OCTA) examination.Results: CKD 1–2 group (versus control group) had greater odds of having decreased retinal ganglion cell-inner plexiform layer thickness (GC-IPLt) (odds ratio [OR]: 0.92; 95% confidence interval [CI]: 0.86–0.98), increased ganglion cell complex-focal loss volume (GCC-FLV) (OR: 3.51; 95% CI: 1.27–9.67), and GCC-global loss volume (GCC-GLV) (OR: 2.48; 95% CI: 1.27–4.82). The presence of advanced stages of CKD (CKD 3–5 group versus CKD 1–2 group) had greater odds of having decreased retinal vessel density in superficial vascular plexus (SVP)-WholeImage (OR: 0.77, 95% CI: 0.63–0.92), SVP-ParaFovea (OR: 0.83, 95% CI: 0.71–0.97), SVP-ParaFovea (OR: 0.76, 95% CI: 0.63–0.91), deep vascular plexus (DVP)-WholeImage (OR: 0.89, 95% CI: 0.81–0.98), DVP-ParaFovea (OR: 0.88, 95% CI: 0.78–0.99), and DVP-PeriFovea (OR: 0.90, 95% CI: 0.83–0.98). Besides, stepwise multivariate linear regression among CKD patients showed that β2-microglobulin was negatively associated with GC-IPLt (β: –0.294; 95% CI: –0.469 ∼ –0.118), and parathyroid hormone was positively associated with increased GCC-FLV (β: 0.004; 95% CI: 0.002∼0.006) and GCC-GLV (β: 0.007; 95% CI: 0.004∼0.01). Urine protein to creatinine ratio was positively associated with increased GCC-FLV (β: 0.003; 95% CI: 0.001∼0.004) and GCC-GLV (β: 0.003; 95% CI: 0.001∼0.006).Conclusion: Retinal neuronal impairment is present in early stages of CKD (stages 1–2), and it is associated with accumulation of uremic toxins and higher UACR, while retinal microvascular hypoperfusion, which is associated with worse eGFR, was only observed in relatively advanced stages of CKD (stages 3–5). The results highlight the importance of monitoring retinal neurovascular impairment in different stages of CKD.
first_indexed 2024-12-14T08:02:19Z
format Article
id doaj.art-1dd9c39fa407474a82dd245b1954614d
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-12-14T08:02:19Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-1dd9c39fa407474a82dd245b1954614d2022-12-21T23:10:19ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2021-11-011510.3389/fnins.2021.703898703898Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease PatientsXiaomin Zeng0Xiaomin Zeng1Yijun Hu2Yijun Hu3Yuanhan Chen4Zhanjie Lin5Zhanjie Lin6Yingying Liang7Yingying Liang8Baoyi Liu9Baoyi Liu10Pingting Zhong11Pingting Zhong12Yu Xiao13Yu Xiao14Cong Li15Cong Li16Guanrong Wu17Guanrong Wu18Huiqian Kong19Huiqian Kong20Zijing Du21Zijing Du22Yun Ren23Yun Ren24Ying Fang25Zhiming Ye26Xiaohong Yang27Xiaohong Yang28Honghua Yu29Honghua Yu30Guangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaThe Second School of Clinical Medicine, Southern Medical University, Guangzhou, ChinaAier Institute of Refractive Surgery, Refractive Surgery Center, Guangzhou Aier Eye Hospital, Guangzhou, ChinaAier School of Ophthalmology, Central South University, Changsha, ChinaDivision of Nephrology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaGuangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaShantou University Medical College, Shantou, ChinaGuangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaThe Second School of Clinical Medicine, Southern Medical University, Guangzhou, ChinaGuangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaThe Second School of Clinical Medicine, Southern Medical University, Guangzhou, ChinaGuangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaShantou University Medical College, Shantou, ChinaGuangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaThe Second School of Clinical Medicine, Southern Medical University, Guangzhou, ChinaGuangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaSchool of Medicine, South China University of Technology, Guangzhou, ChinaGuangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaSchool of Medicine, South China University of Technology, Guangzhou, ChinaGuangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaThe Second School of Clinical Medicine, Southern Medical University, Guangzhou, ChinaGuangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaThe Second School of Clinical Medicine, Southern Medical University, Guangzhou, ChinaGuangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaShantou University Medical College, Shantou, ChinaGuangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaDivision of Nephrology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaGuangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaThe Second School of Clinical Medicine, Southern Medical University, Guangzhou, ChinaGuangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaThe Second School of Clinical Medicine, Southern Medical University, Guangzhou, ChinaBackground: Widespread neural and microvascular injuries are common in chronic kidney disease (CKD), increasing risks of neurovascular complications and mortality. Early detection of such changes helps assess the risks of neurovascular complications for CKD patients. As an extension of central nervous system, the retina provides a characteristic window to observe neurovascular alterations in CKD. This study aimed to determine the presence of retinal neurovascular impairment in different stages of CKD.Methods: One hundred fifteen non-diabetic and non-dialytic CKD patients of all stages and a control group of 35 healthy subjects were included. Retinal neural and microvascular parameters were obtained by optical coherence tomography angiography (OCTA) examination.Results: CKD 1–2 group (versus control group) had greater odds of having decreased retinal ganglion cell-inner plexiform layer thickness (GC-IPLt) (odds ratio [OR]: 0.92; 95% confidence interval [CI]: 0.86–0.98), increased ganglion cell complex-focal loss volume (GCC-FLV) (OR: 3.51; 95% CI: 1.27–9.67), and GCC-global loss volume (GCC-GLV) (OR: 2.48; 95% CI: 1.27–4.82). The presence of advanced stages of CKD (CKD 3–5 group versus CKD 1–2 group) had greater odds of having decreased retinal vessel density in superficial vascular plexus (SVP)-WholeImage (OR: 0.77, 95% CI: 0.63–0.92), SVP-ParaFovea (OR: 0.83, 95% CI: 0.71–0.97), SVP-ParaFovea (OR: 0.76, 95% CI: 0.63–0.91), deep vascular plexus (DVP)-WholeImage (OR: 0.89, 95% CI: 0.81–0.98), DVP-ParaFovea (OR: 0.88, 95% CI: 0.78–0.99), and DVP-PeriFovea (OR: 0.90, 95% CI: 0.83–0.98). Besides, stepwise multivariate linear regression among CKD patients showed that β2-microglobulin was negatively associated with GC-IPLt (β: –0.294; 95% CI: –0.469 ∼ –0.118), and parathyroid hormone was positively associated with increased GCC-FLV (β: 0.004; 95% CI: 0.002∼0.006) and GCC-GLV (β: 0.007; 95% CI: 0.004∼0.01). Urine protein to creatinine ratio was positively associated with increased GCC-FLV (β: 0.003; 95% CI: 0.001∼0.004) and GCC-GLV (β: 0.003; 95% CI: 0.001∼0.006).Conclusion: Retinal neuronal impairment is present in early stages of CKD (stages 1–2), and it is associated with accumulation of uremic toxins and higher UACR, while retinal microvascular hypoperfusion, which is associated with worse eGFR, was only observed in relatively advanced stages of CKD (stages 3–5). The results highlight the importance of monitoring retinal neurovascular impairment in different stages of CKD.https://www.frontiersin.org/articles/10.3389/fnins.2021.703898/fullretinal imagingneuronal impairmentmicrovascular hypoperfusionoptical coherence tomography angiography (OCTA)chronic kidney disease
spellingShingle Xiaomin Zeng
Xiaomin Zeng
Yijun Hu
Yijun Hu
Yuanhan Chen
Zhanjie Lin
Zhanjie Lin
Yingying Liang
Yingying Liang
Baoyi Liu
Baoyi Liu
Pingting Zhong
Pingting Zhong
Yu Xiao
Yu Xiao
Cong Li
Cong Li
Guanrong Wu
Guanrong Wu
Huiqian Kong
Huiqian Kong
Zijing Du
Zijing Du
Yun Ren
Yun Ren
Ying Fang
Zhiming Ye
Xiaohong Yang
Xiaohong Yang
Honghua Yu
Honghua Yu
Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients
Frontiers in Neuroscience
retinal imaging
neuronal impairment
microvascular hypoperfusion
optical coherence tomography angiography (OCTA)
chronic kidney disease
title Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients
title_full Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients
title_fullStr Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients
title_full_unstemmed Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients
title_short Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients
title_sort retinal neurovascular impairment in non diabetic and non dialytic chronic kidney disease patients
topic retinal imaging
neuronal impairment
microvascular hypoperfusion
optical coherence tomography angiography (OCTA)
chronic kidney disease
url https://www.frontiersin.org/articles/10.3389/fnins.2021.703898/full
work_keys_str_mv AT xiaominzeng retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT xiaominzeng retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yijunhu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yijunhu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yuanhanchen retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT zhanjielin retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT zhanjielin retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yingyingliang retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yingyingliang retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT baoyiliu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT baoyiliu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT pingtingzhong retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT pingtingzhong retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yuxiao retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yuxiao retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT congli retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT congli retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT guanrongwu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT guanrongwu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT huiqiankong retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT huiqiankong retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT zijingdu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT zijingdu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yunren retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yunren retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yingfang retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT zhimingye retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT xiaohongyang retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT xiaohongyang retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT honghuayu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT honghuayu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients